Post Marketing Information PEM 21/08/2024 SOLIRIS® (eculizumab): PHYSICIAN’S GUIDE: Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), and Neuromyelitis Optica Spectrum Disorder (NMOSD) PMG 21/08/2024 SOLIRIS® (eculizumab): Patient/Parent/Legal Guardian Guide: Paroxysmal Nocturnal Hemoglobinuria (PNH), Atypical Hemolytic Uremic Syndrome (aHUS), Generalized Myasthenia Gravis (gMG), and Neuromyelitis Optica Spectrum Disorder (NMOSD) PAC 21/08/2024 Patient Safety Information Card: SOLIRIS® (eculizumab)
General Availability in Public Healthcare Institution Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration Soliris Infusion, Solution Concentrate 300 mg/vial National University Hospital
INTRAVENOUS Select a brand starting with the letter: S SOLIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL [SIN14226P]